Industry News
September 2, 2010Submit your candidate for the Fierce 15
September 2, 2010Antibiotic gets positive FDA staff assessment
September 2, 2010Analysts: New FDA rules inspire tougher drug reviews
September 2, 2010Nobel Prize-winner finds new path for Alzheimer's drug
September 2, 2010Genzyme dickers over sales deals as Sanofi dangles
September 2, 2010Cardiome shares jump after vernakalant OK triggers $30M milestone
September 2, 2010Orexigen and Takeda ink a billion-dollar pact on weight loss drug
September 1, 2010Last call: Deadline looms for 2010 Fierce 15
September 1, 2010Theratechnologies names Huss president, CEO
September 1, 2010Celator gains $20M round for cancer drug dev
September 1, 2010Archimedes snags EMA approval for new pain therapy
September 1, 2010Pfizer buys FoldRx for rare disease division
September 1, 2010Cellerant lands $153M BARDA contract for ARS program
September 1, 2010PhIII: Liver enzymes spike in 7% of mipomersen group
September 1, 2010Termeer insists Genzyme is worth much more than $18.5B
August 31, 2010Bayer, Kythera ink $373M dermatology deal
August 31, 2010Achaogen wins $64M biodefense contract
August 31, 2010AMT looks for funding while it waits for EMA approval
August 31, 2010Endo looks for more acquisitions
August 31, 2010Apixaban, Xarelto deliver good results in studies
August 30, 2010Genzyme rejects Sanofi's $18.5B offer
August 30, 2010Eisai heart drug may lower heart risks
August 30, 2010FDA wants more data on AZ's motavizumab
August 30, 2010Otonomy lands $38.5M for ear disorder work
August 30, 2010ImmunoSolv merges to avoid 'one trick pony' syndrome
August 30, 2010Top 10 Women in Biotech
August 30, 2010Novartis set to begin late-stage testing of blood thinner
August 30, 2010Top 10 Women in Biotech
August 30, 2010Katrine Bosley – Top 10 Women in Biotech
August 30, 2010Susan Desmond-Hellman – Top 10 Women in Biotech